We scan new podcasts and send you the top 5 insights daily.
Despite some investors demanding "explosive," AI-fueled 1000%+ YoY growth, the traditional high-growth model (e.g., 3x YoY at eight-figure ARR) remains a valid path. Investor Eric Byunn believes the market will revert to valuing this durable growth profile, which may be out of favor but is not obsolete.
The venture capital benchmark for elite growth has shifted for AI companies. The old "T2D3" (Triple, Triple, Double, Double, Double) heuristic for SaaS is no longer the gold standard. Investors now consider achieving $100M ARR in under three years as the strongest signal of exceptional product-market fit in AI.
Oren Zeev argues the market's obsession with triple-digit growth is dangerous, driving unhealthy behaviors like circular revenue deals. He prefers a company doubling annually with healthy economics over one tripling with unsustainable practices, as the fundamental math of compounding has not changed.
In the current AI boom, companies are raising subsequent funding rounds at the same high revenue multiples as previous ones, months apart. This is because growth rates aren't decelerating as expected, challenging the wisdom that valuation multiples must compress as revenue scales.
The VC market is obsessed with AI companies showing "zero to 100 in a year" growth. This creates a blind spot for high-quality, traditional software companies. A business growing 5x annually is a fantastic investment by any historical standard but now struggles for attention.
Investors' obsession with companies growing "from zero to 100 in a year" has led them to neglect fundamentally strong enterprise software businesses. This creates an arbitrage opportunity for those willing to back solid companies with great, albeit not exponential, growth in large markets.
The bar for early-stage funding has shifted dramatically. While 3x year-over-year growth was once impressive, investors now seek unprecedented acceleration, often modeling companies that go from $1M to $100M ARR in a year. This leaves many solid, compounding businesses unable to secure traditional venture capital.
The narrative of "0 to $100M in a year" often reflects a startup's dependence on a larger, fast-growing customer (like an AI foundation model company) rather than intrinsic product superiority. This growth is a market anomaly, similar to COVID testing labs, and can vanish as quickly as it appeared when competition normalizes prices and demand shifts.
Financial models struggle to project sustained high growth rates (>30% YoY). Analysts naturally revert to the mean, causing them to undervalue companies that defy this and maintain high growth for years, creating an opportunity for investors who spot this persistence.
The traditional SaaS growth metric for top companies—reaching $1M, $3M, then $10M in annual recurring revenue—is outdated. For today's top-decile AI-native startups, the new expectation is an accelerated path of $1M, $10M, then $50M, reflecting the dramatically faster adoption cycles and larger market opportunities.
Relying on the once-golden 'T2D3' growth metric for SaaS companies is now terrible advice for 2025. The market has shifted, and founders with these strong historical metrics are still struggling to get funded, indicating that even elite growth is no longer a guarantee of investment.